• The Weight-Loss Gold Rush: Legal and Regulatory Implications

  • Jul 11 2024
  • Length: 17 mins
  • Podcast

The Weight-Loss Gold Rush: Legal and Regulatory Implications

Listen for free

View show details

  • Summary

  • Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses:
    • Top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs
    • How the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs
    • What needs to be done for GLP-1s to be covered
    • Steps companies developing weight-loss medications should take to ensure responsible and ethical practice
    • Advice for investors and financiers who are considering entering the weight-loss medication market
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about The Weight-Loss Gold Rush: Legal and Regulatory Implications

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available